reading retatrutide threads from 2024 and half of it aged badly
reading retatrutide threads from 2024 and half of it aged badly. Not a hot take, just something I have not seen said plainly here. The thing that surprised me was how much of the discussion here is inference rather than measurement. Watched heart rate on a wearable across twelve weeks because the threads said to. It…
Yes — the comparison threads are apples to oranges and they generate more heat than anything else here.
triple agonist — GLP-1, GIP and glucagon, and the glucagon arm is the new part
Right, and it bears repeating that nothing here is approved anywhere and research material is not for human use.
the TRIUMPH programme is still running, so anything definitive is premature
Has anyone posted an independent test on this compound recently?
the energy-expenditure story is mechanistically interesting and clinically unproven
Small fix — three receptors, not two. GLP-1, GIP and glucagon, and the third one is the reason this compound gets its own board.
not approved anywhere, which is the single most important fact in this board
the phase 2 numbers were striking and they were also 48 weeks in a small population